TCM
Tekla Capital Management Portfolio holdings
AUM
$2.56B
This Quarter Return
+14.35%
1 Year Return
+18.15%
3 Year Return
+62.34%
5 Year Return
+140.22%
10 Year Return
+499.57%
AUM
$2.65B
AUM Growth
+$2.65B
(+8.4%)
Cap. Flow
-$85M
Cap. Flow
% of AUM
-3.21%
Top 10 Holdings %
Top 10 Hldgs %
39.13%
Holding
181
New
13
Increased
25
Reduced
35
Closed
9
Top Buys
| 1 |
Eli Lilly
LLY
|
$17.7M |
| 2 |
Pfizer
PFE
|
$16.7M |
| 3 |
Biogen
BIIB
|
$13.8M |
| 4 |
McKesson
MCK
|
$12.3M |
| 5 |
Avantor
AVTR
|
$9.69M |
Top Sells
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$36.3M |
| 2 |
Johnson & Johnson
JNJ
|
$25.5M |
| 3 |
Humana
HUM
|
$18.1M |
| 4 |
AstraZeneca
AZN
|
$17M |
| 5 |
Molina Healthcare
MOH
|
$15.2M |
Sector Composition
| 1 | Healthcare | 97.55% |
| 2 | Real Estate | 1.68% |
| 3 | Industrials | 0.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
176
Health Care Select Sector SPDR Fund
XLV
$33.9B
| – | – | -29,024 | Closed | -$3.52M |
|
|
CCXI
177
DELISTED
ChemoCentryx, Inc.
CCXI
| – | – | -78,197 | Closed | -$4.04M |
|
|
ENDP
178
DELISTED
Endo International plc
ENDP
| – | – | -494,607 | Closed | -$48K |
|
|
BHVN
179
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| – | – | -70,176 | Closed | -$10.6M |
|